Past editions of the Lasker Prize in Medicine

Basic Medical Research Award: Ernest A. McCulloch and James E. Till of the Ontario Cancer Institute at the University of Toronto received the Basic Medical Research Award for stem cell research;

Clinical Medicine Award: Edwin Southern of the University of Oxford and Alec J. Jeffreys of the University of Leicester, England ( University of Oxford and Alec J. Jeffreys of the University of Leicester received the Clinical Medicine Award for their contributions to Southern Blotting and DNA fingerprinting methods, respectively;

Public **** Service Award: Nancy Brinker, who founded the Susan G. Komen Breast Cancer Foundation, which has helped many patients with breast cancer and funded much cancer research. Basic Medicine Award: Dr. Elizabeth Blackburne, University of California, San Francisco; Carol Greider, Johns Hopkins School of Medicine, Baltimore; and Jack Zostak, Harvard Medical School and Howard Hughes Medical Institute.

Clinical Medical Research Award: Australian-born stem cell researcher Dr. Blackburn; Aaron Baker, professor emeritus at the University of Pennsylvania School of Medicine,

Lasker Prize for Special Achievement in Medicine: Joseph Gale of the Department of Embryology at the Carnegie Institution of Medicine in Baltimore. Basic Medicine Award: surgeon Dr. Alain Carpentier of the Georges Pompidou School of Medicine in Paris, France, and surgeon Dr. Albert Stell of the Providence Health System in Portland, Ore.

Clinical Medical Research Award: Dr. Ralph Stallman, Rockefeller University, USA.

Lasker Public **** Service Award: Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. Basic Medicine Award: Victor Ambros of the University of Massachusetts Medical School, Gary Ruvkun of Massachusetts General Hospital, and David Baulcombe of Columbia University in the U.K.

Special Contributions to Medical Science Award: Stanley Falkow has established a set of guidelines for discriminating between genes of disease-causing microorganisms that cause disease in their hosts, known as virulence factors. (virulence factor). Basic Medicine Award: John Gurdon, University of Cambridge, England, and Shinya Yamanaka, Kyoto University, Japan;

Clinical Medical Research Award: Brian Druker, Oregon Health & Science University, Portland, and Nicholas Lydon, Granite Biopharma Consultants, San Diego (formerly of Novartis). Lydon, formerly of Novartis, and Charles Sawyers of Memorial Sloan-Kettering Cancer Research Center, New York City. Basic Medicine Award: Arthur Horwich of Yale University School of Medicine, USA, and Franz Liszt of the Max Planck Institute of Biochemistry, Germany. Biochemistry, Germany, and Franz-Ulrich Hartl of the Max Planck Institute of Biochemistry, Germany.

Prize for Clinical Medical Research: Chinese scientist Tu Youyou. The reason for the award is "for the discovery of artemisinin, a drug used in the treatment of malaria, which has saved millions of lives around the world, especially in developing countries. Tu Youyou became the first mainland Chinese scientist to receive this award. In September 2013, the Lasker Foundation announced the winners of the 2013 Albert Lasker Award, and five scientists were honored in 2013***.

Basic Medicine Award: Richard H. Scheller of Genentech, Inc. and Thomas C. Sdhof of Stanford University School of Medicine, U.S.A. The reason for the award is the "discovery of the molecular machinery and regulatory mechanisms behind the rapid release of neurotransmitters". ".

The Clinical Medicine Award: Graeme M. Clark, Professor Emeritus, University of Melbourne, Australia; Ingeborg Hochmair, MED-EL Cochlear Implants, Innsbruck, Austria; and Blake S. Wilson, Duke University, U.S.A. The award was given for "the development of the modern cochlear implant, a device that has been used to treat severe deafness for many years".

Public **** Service Award: Mr. and Mrs. Bill Gates. Awarded for "historically changing the way we look at global health issues and improving the lives of millions of the world's poor." September 8, 2014 - Five researchers working on a cellular system for repairing misfolded proteins, deep brain stimulation for Parkinson's disease, and a gene for breast cancer have won this year's Lasker Prize for biomedical research.

Basic Medical Research Award: to Kazutoshi Mori, 56, a researcher at Kyoto University in Japan, and Peter Walter, 59, of the University of California, San Francisco, for their work on unfolded protein responses.

Clinical Research Award: Alim Louis Benabid, 72, from the Université Joseph Fourier in Grenoble, France, and Mahlon DeLong, 76, from Emory University in the United States, received the Lasker. Their research, which also began in the 1980s, showed in animal and human trials that using a device surgically implanted in the brain could stimulate the thalamus-fundamental nucleus and slow down tremors and other symptoms in people with Parkinson's. In 2002, U.S. regulators approved the treatment for Parkinson's.

Special Achievement Award: Mary-Claire King, 68, a researcher at the University of Washington, received the Lasker for her discovery of the BRCA1 breast cancer risk gene in 1990 and her development of a method of analyzing DNA to identify a family member. The method was first used to help parents find children separated during the 1976-1983 military dictatorship in Argentina, and has since been used to identify victims of natural disasters and the September 11 terrorist attacks. Basic Medical Research Award

Stephen J. Elledge of Brigham and Women's Hospital at Harvard Medical School and Evelyn M. Witkin of Rutgers University have been honored with the 2015 Lasker Award for Basic Medical Research. The duo took home the award for their discovery of the DNA-damage response.

Clinical Medical Research Award

James Alison of The University of Texas M.D. Anderson Cancer Center won the award for his discovery of a monoclonal therapy that stimulates the immune system to fight cancer.

Public Service Award

The 2015 Lasker-Bloomberg Public Service Award goes to Doctors Without Borders. Last year's Ebola outbreak in West Africa was a fast-moving and intensifying one. MSF played a leading role in saving the day at a critical time when the country's health system was facing collapse.